Abstract

Volume.121 Number.2

Original article : Clinical science

Results of the Baerveldt® Glaucoma Implant for Neovascular Glaucoma Patients
Naoki Tojo, Tomoko Nakamura, Tomoko Consolvo Ueda, Shuichiro Yanagisawa, Atsushi Hayashi
Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama

Purpose: To evaluate the efficacy and safety of the Baerveldt® glaucoma implant (BGI) for eyes with neovascular glaucoma (NVG).
Methods: This was a retrospective study. Thirty-five eyes (31 patients) diagnosed with refractory NVG at Toyama University Hospital were enrolled from January 2012 to December 2015. All patients underwent BGI and were followed up for more than 6 months.
Results: The mean age of patients was 62.7±13.9 years old. The mean postoperative follow-up periods was 22.0±12.7 months. The mean preoperative IOP was 35.5±9.6 mmHg and the mean postoperative IOP at 6, 12, 24, 36, 48 month were 12.7±5.9, 12.8±3.7, 12.2±3.3, 13.1±3.3, 15.0±1.4 mmHg respectively. Postoperative visual acuity was not significantly improved. Complications were Hoffmann Elbow erosion in 2 patients who needed additional surgery. The success rate at one year was 82.7%. Postoperative intervention was not required.
Conclusion: BGI surgery should be considered a useful treatment to lower the IOP for NVG.
Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc) 121: 138-145, 2017.

Key words
Baerveldt®, glaucoma implant, Neovascular glaucoma, Intraocular pressure, Postoperative complication, Diabetic retinopathy
Reprint requests to
Naoki Tojo, M.D. Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama. 2630 Sugitani, Toyama-shi 930-0194, Japan